We’re pleased to share our latest preprint on medRxiv: a Controlled Human Malaria Infection model for relapsing Plasmodium vivax. This collaborative study from Oxford, Radboudumc and the OptiViVax consortium reports the safety and feasibility of a novel relapsing P. vivax CHMI model.
New pre-print!
optivivax.site.ox.ac.uk